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Abstract
Background Esophageal perforations and postoperative
leakage of esophagogastrostomy are considered to be life-
threatening conditions due to the development of medias-
tinitis and consecutive sepsis. Vacuum-assisted closure
(VAC), a well-established treatment method for superficial
infected wounds, is based on a negative pressure applied to
the wound via a vacuum-sealed sponge. Endoluminal VAC
(E-VAC) therapy is a novel method, and experience with
its esophageal application is limited.
Methods This retrospective study summarizes the expe-
rience of a center with a high volume of upper gastroin-
testinal surgery using E-VAC therapy for patients with
leakages of the esophagus. The study investigated 14
patients who had esophageal defects treated with E-VAC.
Three patients had a spontaneous defect; two patients had
an iatrogenic defect; and nine patients had a postoperative
esophageal defect.
Results The average duration of application was 12.1 days,
and an average of 3.9 E-VAC systems were used. For 6 of the
14 patients, E-VAC therapy was combined with the place-
ment of self-expanding metal stents. Complete restoration of
the esophageal defect was achieved in 12 (86 %) of the 14
patients. Two patients died due to prolonged sepsis.
Conclusion This report demonstrates that E-VAC therapy
adds an additional treatment option for partial esophageal
wall defects. The combination of E-VAC treatment and
endoscopic stenting is a successful novel procedure for
achieving a high closure rate.
Keywords Esophageal perforation  Anastomotic
leakage  Endoscopic vacuum-assisted closure system
Spontaneous and iatrogenic esophageal perforations as well
as postoperative leaks of esophagogastrostomy and
esophagojejunostomy are considered to be life-threatening
conditions due to the development of mediastinitis and
consecutive sepsis [1]. Possible treatment options must
drain the septic focus in the mediastinum and close the
esophageal wall defect or the dehiscent circular stapler line
of the anastomoses.
Self-expanding metal or plastic stents are widely used
for these complications and successfully achieve a closure
of the defect in most cases [2]. However, in some patients,
sepsis persists due to an undrained mediastinal abscess
formation, which often is difficult to address by interven-
tional radiologic means. In these cases, surgical resection
of the defective esophageal tube or the gastric conduit is
required for safe treatment of the mediastinal septic focus
and prevention of progressive multiple organ failure [1].
This surgical treatment option severely impairs the
patient’s quality of life and usually is associated with a
complicated two-stage esophageal reconstruction.
Vacuum-assisted closure (VAC) is a well-established
treatment method for superficial infected wounds based on
a negative pressure applied to the wound via a vacuum-
sealed sponge [3]. The sponge continuously removes
wound secretion and interstitial edema, improves micro-
circulation, and therefore induces an accelerated formation
of granulation tissue, resulting in closure of the infected
wound.
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and Other Interventional Techniques 
Clinical experience with application of the VAC system
from the endoluminal intestinal side, first attempted for
fistulas of rectal anastomoses, has been sparse [4]. This
report summarizes the experience of an esophageal high-
volume center using endoluminal VAC (E-VAC) for
patients with spontaneous, iatrogenic, or postoperative
leaks of the tubular esophagus.
Patients and methods
In this retrospective study, 14 patients (6 women and 8
men) with esophageal defects were treated using the
E-VAC between October 2010 and December 2012. The
average age of the patients was 67.2 years (range,
43–86 years) (Table 1). The study was approved by the
Ethics Committee of the University of Cologne.
The primary outcome of the study was leak closure.
Complications and side effects of E-VAC therapy also
were evaluated (Table 2).
The esophageal defects were classified into two groups:
iatrogenic and spontaneous perforations (n = 6) and
anastomotic leakages (n = 8). Two patients in the first
group had a Boerhaave syndrome, and one patient had a
perforation due to a systemic sclerodermia. Iatrogenic
perforations occurred during mediastinoscopy (n = 1),
after thoracoscopic enucleation of a leiomyoma (n = 1),
and during endoscopic dilation of a benign esophageal
stenosis (n = 1). Eight patients in the second group expe-
rienced an anastomotic leakage after esophagectomy
(n = 5) or after gastrectomy (n = 3).
For 12 patients, the leakage was diagnosed by an endo-
scopic examination. For two patients, a contrast swallow
determined the diagnosis, and a subsequent computed
tomography (CT) scan confirmed the existence of the leak.
E-VAC treatment
All endoscopic interventions were performed either with
the patient either under conscious sedation using propofol
(Fresenius Kabi, Bad Homburg, Germany) or under general
anesthesia.
After the esophageal defect had been located, its size
was estimated. In case of a large orifice, the cavity was
examined with the endoscope, and an endowasher was used
via the working channel of the endoscope to clean the
cavity. Then E-VAC therapy was applied by endoscopic
insertion of the Endo-SPONGE system (B. Braun Mels-
ungen AG, Melsungen, Germany) through the esophageal
defect into the cavity.
The Endo-SPONGE consists of an open-pored polyure-
thane sponge cut to fit into the paraesophageal cavity. The
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leak and placed with the grasper forceps into the para-
esophageal cavity (intracavitary vacuum therapy, Fig. 1). In
case of a small orifice, the polyurethane sponge was placed at
the level of the esophageal wall defect (intraluminal vacuum
therapy, Fig. 2). The sponge was connected with a naso-
gastric tube, and suction was applied to this system by a
portable pump. Secretions were continuously evacuated
using a negative pressure of 100 mmHg.
After the endoscopic intervention, the patients were
awake, spontaneously breathing, and usually capable of
being managed on a peripheral ward. The nasogastric tube
generally was well tolerated without major problems.
After 2–3 days of continuous suction, the sponge was
removed after inactivation of the vacuum by pulling at the
nasogastric tube. In case the sponge was adherent to the
adjacent tissue, it was removed with aid of an endoscopic
Table 2 Overview of published case series
Author No. of treated
patients






Wedemeyer et al. [8] 2 PL 5 15 2/2 (100)
Wedemeyer et al. [9] 8 PL 7 23 (15–31) 7/8 (88)
Ahrens et al. [15] 5 PL 9 (8–12) 28 (24–38) 5/5 (100)
Weidenhagen et al. [11] 6 PL 10 (5–16) 45 (32–84) 5/6 (83)
Loske et al. [13] 14 3 9 SP 4 (1–10) 12 (4–31) 13/14 (93)
3 9 IP
8 9 PL
Kuehn et al. [16] 9 1 9 SP 6 (1–13) 3.5 8/9 (89)
1 9 IP
7 9 PL
Schorsch et al. [14] 24 7 9 IP 3.7 (1–12)a 11 (4–46) 23/24 (96)
17 9 PL
Brangewitz et al. [17] 32 1 9 SP 3.2 (5–28)a 23 (9–86) 27/32 (84)
1 9 IP
30 9 PL
Bludau et al. [18] 14 3 9 SP 3.9 (1–9) 12.1 (3–23) 12/14 (86)
3 9 IP
8 9 PL
E-VAC endoluminal vacuum-assisted closure, PL postoperative leak, SP spontaneous perforation, IP iatrogenic perforation
a Value calculated
Fig. 1 Intracavitary application of endoluminal vacuum-assisted
closure (E-VAC)
Fig. 2 Intraluminal application of endoluminal vacuum-assisted
closure (E-VAC)
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forceps. After complete removal, the result of E-VAC
therapy was controlled endoscopically (Fig. 3).
In some patients, the procedure was combined with
endoscopic stenting of the leakage (Table 1). This was
done when E-VAC therapy did not drain any further
infectious secretions although the esophageal wall defect
was not closed. This persisting leakage was covered with a
self-expanding metal stent (SEMS) (Ultrapro 23/28 mm;
Boston Scientific, Boston, MA). After a period of
4–6 weeks, the stent was removed.
Results
Table 1 summarizes the main characteristics of the 14
patients who underwent esophageal E-VAC therapy. The
average duration of application was 12.1 days per patient.
An average of 3.9 systems per patient were used (interval
between changes, 3.1 days; range, 3–5 days). One patient
had complete closure of the defect without a change of
systems. Complete restoration of the esophageal wall was
achieved in 12 (87 %) of the 14 patients.
For 6 of the 14 patients, E-VAC therapy was combined
with the placement of SEMS. In all cases, the stent was
placed after the E-VAC therapy. The closure was con-
firmed by a CT scan with oral contrast or a contrast
swallow before the patient was allowed to begin oral
intake.
For 3 of the 14 patients, enteral feeding was possible
with insertion of an endoscopic feeding tube (n = 2) or
placement of a gastropexy percutaneous endoscopic gas-
trostomy (PEG) (n = 1).
Two patients died due to severe mediastinitis and con-
secutive sepsis before E-VAC therapy could be success-
fully completed. The first patient was 87-year old man with
Boerhaave syndrome. Due to prolongation of this diagno-
sis, a septic course developed before drainage of a pleural
effusion confirmed the underlying condition. The second
patient, a 74-year-old man, had a gastric cancer with gas-
trectomy and Roux-en-Y reconstruction. The patient
experienced anastomotic leakage of the esophagojejunos-
tomy in the lower mediastinum. After confirmation of the
diagnosis on postoperative day 5, the patient was trans-
ferred to our department. Both patients died due to a
therapy-resistant sepsis after prolonged therapy of the
esophageal leak.
Follow-up endoscopy was performed for 11 of the 14
patients. The mean follow-up period was 106 days (range,
10–335 days). In two cases, an esophageal stenosis was
diagnosed, which was treated successfully by one-time
pneumatic dilation. Otherwise, no complications related to
the E-VAC therapy were observed.
Discussion
Esophageal perforations as well as postoperative leaks of
esophagogastrostomy and mediastinal esophagojejunosto-
my usually cause the development of mediastinitis and
consecutive sepsis [1, 5]. However, for these esophageal
defects, surgical resection was the mainstay for a long
period. Interventional mostly endoscopic treatments have
replaced surgical techniques.
Endoscopic treatment consists predominantly of apply-
ing different endoscopic stents. This treatment has proved
to be as effective as surgical resection [2]. In addition,
reports describe the instillation of fibrin glue into the
leakage until the defect is plugged [6, 7]. This technique is
used only for very small leaks.
As a new alternative treatment for esophageal perfora-
tion or postoperative leakages, E-VAC therapy was intro-
duced some years ago. The first experience with E-VAC
application in the upper gastrointestinal (GI) tract was
published as a case report in 2008 [8]. In two patients, the
esophageal defect was successfully closed with E-VAC
therapy.
In further studies, the technique was modified [9–14]
and demonstrated to be a feasible and safe procedure. In 13
(92 %) of 14 patients, Loske et al. [12] showed a successful
closure of esophageal leaks with intracavitary or intralu-
minal placement of the sponge. Only one patient experi-
enced a stenosis during the follow-up period. This
complication was confirmed in a small series of five
patients with two stenoses that required further endoscopic
treatment [15]. In another series, Wedemeyer et al. [9]
Fig. 3 After endoluminal vacuum-assisted closure (E-VAC)
treatment
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demonstrated similar success rates with eight patients, and
no major complications occurred during a follow-up period
longer than 6 months.
Kuehn et al. [16] reported on E-VAC used for nine
patients. Four of the nine patients were treated with a hybrid
procedure consisting of an initial endoscopic intervention
with E-VAC followed by an open revision operation of the
thoracic cavity. The mean number of sponge insertions was
six, with the sponges changed every 3.5 days. A successful
closure was achieved in eight of the nine patients.
Comparison of the published series with our results
demonstrated a similar closure rate of 86 %. The average
numbers of E-VAC treatments and intervals also were
comparable. In our case study, we could prove that patients’
tolerance and comfort were acceptable. The majority of the
patients required only sedation for endoscopy and could be
managed on a normal ward without intensive care unit (ICU)
support. This contrasts with other reports. In the first study of
E-VAC therapy, the patients had to be treated in the ICU with
mechanical ventilation under general anesthesia [9].
In the latest published study on the treatment of
esophageal leaks, the results of 39 patients with a stent
(SEMS or self-expanding plastic stent [SEPS]) were
compared with 32 patients after E-VAC therapy [17]. The
overall closure rate was 84 % in the E-VAC group, which
was significant higher than the rate of 54 % in the stent
group. However, the characteristics of the patients in the
two groups were very different regarding the surgical
treatment and anastomotic site. The majority of the patients
in the stent group (69 %) underwent esophagogastrostomy,
whereas almost 50 % of the patients in the E-VAC group
underwent reconstruction via an esophagojejunostomy.
The aforementioned anastomotic types differed com-
pletely in terms of vascularization and localization (abdomi-
nal vs intrathoracic). In addition, the diagnosed leaks in the
E-VAC group were significantly larger, so a meaningful
comparison of the two groups is questionable. Taking these
drawbacks into consideration, this retrospective analysis
mainly demonstrated that a clearcut difference between the
two treatment options does not exist currently.
On the other hand, the successful combination of different
endoscopic interventions with E-VAC treatment had several
advantages. First, enteral feeding was possible with insertion
of an endoscopic feeding tube or placement of a percutane-
ous endoscopic gastrostomy (PEG). The combined use of
E-VAC therapy with endoscopic stents was even more
important. In all cases, E-VAC was applied to clean the
perforation cavity and drain the septic focus. After this, the
defect was covered with a stent. With this combined treat-
ment, even large defects could finally be closed.
This study encourages the endoscopic treatment of
upper intestinal leaks using different endoscopic tech-
niques. With E-VAC therapy, clinicians have another
practical endoscopic tool for draining and cleaning a septic
focus of the paraesophageal tissue. It drains septic fluid and
enhances tissue healing. In combination with endoscopic
stent therapy, E-VAC can shift the border between surgical
and endoscopic treatment further toward the less invasive
endoscopic intervention.
The limitations of this method are a persisting or even a
septic course. This mostly indicates that the septic focus is
not adequately drained, and surgical resection should be
considered. In these cases, surgical judgment is of uttermost
importance so the point of reversible sepsis is not missed.
Conclusion
This study confirms the feasibility of E-VAC treatment for
leakages of the esophageal tube. The use E-VAC extends
the spectrum of interventional endoscopy. The combination
of E-VAC therapy followed by endoscopic stenting is a
novel procedure. This hybrid therapy combines the two
surgical treatment strategies for esophageal wall defects:
draining the mediastinal or pleural abscess and closing the
defect of the esophageal tube.
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